About 20 years ago, researchers studying ovarian cancer discovered that many cases of high-grade serous ovarian cancer, the most common type, originate in the fallopian tubes. Detecting the disease there remains challenging, in part because its precursor lesions can be microscopic and difficult to sample.
Now, researchers in the group of MIT Professor Kripa Varanasi, working with colleagues at MIT and Johns Hopkins University, have developed a handheld device capable of gently collecting living cells from specific locations to test for ovarian and many other types of cancer.